Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents

This publication has 22 references indexed in Scilit:

• Development of in vitro susceptibility testing criteria and quality control parameters
  Clinical Microbiology Newsletter, 1989
• In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101
  European Journal of Clinical Microbiology & Infectious Diseases, 1988
• Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing
  Diagnostic Microbiology and Infectious Disease, 1988
• In vitro antimicrobial activity of tigemonam, a new orally administered monobactam
  Antimicrobial Agents and Chemotherapy, 1988
• Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control
  Diagnostic Microbiology and Infectious Disease, 1988
• Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid
  Diagnostic Microbiology and Infectious Disease, 1987